Literature DB >> 26088184

Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment.

Philip A Adeniyi1,2, Azeez O Ishola3, Babafemi J Laoye4, Babawale P Olatunji4, Oluwamolakun O Bankole4, Philemon D Shallie2, Olalekan M Ogundele5,6.   

Abstract

The interaction between MDMA and Nicotine affects multiple brain centres and neurotransmitter systems (serotonin, dopamine and glutamate) involved in motor coordination and cognition. In this study, we have elucidated the effect of prolonged (10 days) MDMA, Nicotine and a combined Nicotine-MDMA treatment on motor-cognitive neural functions. In addition, we have shown the correlation between the observed behavioural change and neural structural changes induced by these treatments in BALB/c mice. We observed that MDMA (2 mg/Kg body weight; subcutaneous) induced a decline in motor function, while Nicotine (2 mg/Kg body weight; subcutaneous) improved motor function in male periadolescent mice. In combined treatment, Nicotine reduced the motor function decline observed in MDMA treatment, thus no significant change in motor function for the combined treatment versus the control. Nicotine or MDMA treatment reduced memory function and altered hippocampal structure. Similarly, a combined Nicotine-MDMA treatment reduced memory function when compared with the control. Ultimately, the metabolic and structural changes in these neural systems were seen to vary for the various forms of treatment. It is noteworthy to mention that a combined treatment increased the rate of lipid peroxidation in brain tissue.

Entities:  

Keywords:  Behaviour; Hippocampus; MDMA; Motor cortex; Nicotine; Striatum

Mesh:

Substances:

Year:  2015        PMID: 26088184     DOI: 10.1007/s11011-015-9691-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  46 in total

1.  Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.

Authors:  Elizabeth Glenn Guy; Paul J Fletcher
Journal:  Pharmacol Biochem Behav       Date:  2014-08-23       Impact factor: 3.533

Review 2.  Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

Authors:  Luke A Downey; Jennifer M Loftis
Journal:  Eur J Pharmacol       Date:  2014-01-28       Impact factor: 4.432

3.  Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.

Authors:  M G Palfreyman; C J Schmidt; S M Sorensen; M W Dudley; J H Kehne; P Moser; M W Gittos; A A Carr
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.

Authors:  Ginetta Collo; Federica Bono; Laura Cavalleri; Laura Plebani; Stefania Mitola; Emilio Merlo Pich; Mark J Millan; Michele Zoli; Uwe Maskos; Pierfranco Spano; Cristina Missale
Journal:  Mol Pharmacol       Date:  2013-03-29       Impact factor: 4.436

5.  The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.

Authors:  Maria Scherma; Zuzana Justinová; Claudio Zanettini; Leigh V Panlilio; Paola Mascia; Paola Fadda; Walter Fratta; Alexandros Makriyannis; Subramanian K Vadivel; Islam Gamaleddin; Bernard Le Foll; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 6.  Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.

Authors:  Donna Seger
Journal:  Clin Toxicol (Phila)       Date:  2010-08       Impact factor: 4.467

7.  Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning.

Authors:  Claudia L R Gonzalez; Omar A Gharbawie; Ian Q Whishaw; Bryan Kolb
Journal:  Synapse       Date:  2005-03-01       Impact factor: 2.562

8.  Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Authors:  Lucina E Lizarraga; Andy V Phan; Aram B Cholanians; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-03-04       Impact factor: 4.849

9.  MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Authors:  John H Anneken; Jacobi I Cunningham; Stuart A Collins; Bryan K Yamamoto; Gary A Gudelsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

10.  Nicotinic acetylcholine receptors containing the α7-like subunit mediate contractions of muscles responsible for space positioning of the snail, Helix pomatia L. tentacle.

Authors:  Tibor Kiss; Nóra Krajcs; Zsolt Pirger; László Hernádi
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more
  4 in total

1.  Curcumin improves episodic memory in cadmium induced memory impairment through inhibition of acetylcholinesterase and adenosine deaminase activities in a rat model.

Authors:  Ayodele Jacob Akinyemi; Princess Kamsy Okonkwo; Opeyemi Ayodeji Faboya; Sunday Amos Onikanni; Adewale Fadaka; Israel Olayide; Elizabeth Olufisayo Akinyemi; Ganiyu Oboh
Journal:  Metab Brain Dis       Date:  2016-08-05       Impact factor: 3.584

2.  Anti-amnestic Effect of Curcumin in Combination with Donepezil, an Anticholinesterase Drug: Involvement of Cholinergic System.

Authors:  Ayodele Jacob Akinyemi; Ganiyu Oboh; Sunday Idowu Oyeleye; Opeyemi Ogunsuyi
Journal:  Neurotox Res       Date:  2017-01-19       Impact factor: 3.911

3.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

4.  Morphine-alcohol treatment impairs cognitive functions and increases neuro-inflammatory responses in the medial prefrontal cortex of juvenile male rats.

Authors:  Adekomi Damilare Adedayo; Adegoke Adebiyi Aderinola; Tijani Ahmad Adekilekun; Olaniyan Olayinka Olaolu; Alabi Mutiyat Olanike; Ijomone Kafilat Olayemi
Journal:  Anat Cell Biol       Date:  2018-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.